106 related articles for article (PubMed ID: 38965541)
1. Adherence to single inhaler triple therapy and digital inhalers in Chronic Obstructive Pulmonary Disease: a literature review and protocol for a randomized controlled trial (TRICOLON study).
Cuperus LJA; van der Palen J; Aldenkamp A; van Huisstede A; Bischoff EWMA; van Boven JFM; Brijker F; Dik S; van Excel JAJM; Goosens M; van Hal PTW; Kuijvenhoven JC; Kunz LIZ; Vasbinder EC; Kerstjens HAM; In 't Veen JCCM;
BMC Pulm Med; 2024 Jul; 24(1):317. PubMed ID: 38965541
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of Users and New Initiators of Single- and Multiple-Inhaler Triple Therapy for Chronic Obstructive Pulmonary Disease in Germany.
Beeh KM; Rothnie KJ; Claussen J; Hardtstock F; Knapp RK; Wilke T; Czira A; Compton C; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2024; 19():945-956. PubMed ID: 38646606
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics, Treatment Persistence, and Outcomes Among Patients With COPD Treated With Single- or Multiple-Inhaler Triple Therapy: A Retrospective Analysis in Spain.
Alcázar-Navarrete B; Jamart L; Sánchez-Covisa J; Juárez M; Graefenhain R; Sicras-Mainar A
Chest; 2022 Nov; 162(5):1017-1029. PubMed ID: 35787391
[TBL] [Abstract][Full Text] [Related]
4. Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting.
Halpin DMG; Rothnie KJ; Banks V; Czira A; Compton C; Wood R; Tritton T; Massey O; Wild R; Snowise N; Nikitin K; Sharma R; Ismaila AS; Vogelmeier CF
Int J Chron Obstruct Pulmon Dis; 2022; 17():2417-2429. PubMed ID: 36185170
[TBL] [Abstract][Full Text] [Related]
5. Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study).
Deslee G; Fabry-Vendrand C; Poccardi N; Thabut G; Eteve Pitsaer C; Coriat A; Renaudat C; Maguire A; Pinto T
BMJ Open Respir Res; 2023 Jun; 10(1):. PubMed ID: 37263738
[TBL] [Abstract][Full Text] [Related]
6. Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States.
Bogart M; Bengtson LGS; Johnson MG; Bunner SH; Gronroos NN; DiRocco KK
Int J Chron Obstruct Pulmon Dis; 2024; 19():97-110. PubMed ID: 38226396
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England.
Rothnie KJ; Joksaite S; Sansbury LB; Compton C; Di Boscio V; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2022; 17():1455-1466. PubMed ID: 35769225
[TBL] [Abstract][Full Text] [Related]
8. Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population.
Bogart M; Stanford RH; Laliberté F; Germain G; Wu JW; Duh MS
Int J Chron Obstruct Pulmon Dis; 2019; 14():343-352. PubMed ID: 30863037
[TBL] [Abstract][Full Text] [Related]
9. Impact of Single Combination Inhaler versus Multiple Inhalers to Deliver the Same Medications for Patients with Asthma or COPD: A Systematic Literature Review.
Zhang S; King D; Rosen VM; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2020; 15():417-438. PubMed ID: 32161454
[TBL] [Abstract][Full Text] [Related]
10. Interventions to improve adherence to pharmacological therapy for chronic obstructive pulmonary disease (COPD).
Janjua S; Pike KC; Carr R; Coles A; Fortescue R; Batavia M
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013381. PubMed ID: 34496032
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effectiveness of inhaler devices in asthma and chronic obstructive airways disease: a systematic review of the literature.
Brocklebank D; Ram F; Wright J; Barry P; Cates C; Davies L; Douglas G; Muers M; Smith D; White J
Health Technol Assess; 2001; 5(26):1-149. PubMed ID: 11701099
[TBL] [Abstract][Full Text] [Related]
12. Adherence and persistence to once-daily single-inhaler versus multiple-inhaler triple therapy among patients with chronic obstructive pulmonary disease in the USA: A real-world study.
Mannino D; Bogart M; Wu B; Germain G; Laliberté F; MacKnight SD; Jung Y; Stiegler M; Duh MS
Respir Med; 2022 Jun; 197():106807. PubMed ID: 35429764
[TBL] [Abstract][Full Text] [Related]
13. Comparison of treatment persistence, adherence, and risk of exacerbation in patients with COPD treated with single-inhaler
Lin L; Liu C; Cheng W; Song Q; Zeng Y; Li X; Deng D; Liu D; Chen Y; Cai S; Chen P
Front Pharmacol; 2023; 14():1147985. PubMed ID: 37025493
[No Abstract] [Full Text] [Related]
14. Clinical characteristics, treatment patterns and adherence in patients with asthma on multiple inhaler triple therapy: a review of findings.
Cazzola M; Calzetta L; Rinaldi B; De Novellis V; Rogliani P; Matera MG
Expert Rev Respir Med; 2022; 16(11-12):1205-1212. PubMed ID: 36629483
[TBL] [Abstract][Full Text] [Related]
15. Real-World Treatment Patterns of Multiple-Inhaler Triple Therapy Among Patients with Chronic Obstructive Pulmonary Disease in UK General Practice.
Sansbury LB; Bains C; Lipson DA; Ismaila AS; Landis SH
Int J Chron Obstruct Pulmon Dis; 2021; 16():1255-1264. PubMed ID: 33986594
[TBL] [Abstract][Full Text] [Related]
16. Outcomes of patients with COPD switching from multiple-inhaler to once-daily single-inhaler triple therapy in a real-world primary care setting in England: a retrospective pre-post cohort study.
Rothnie KJ; Wood RP; Czira A; Banks VL; Camidge LJ; Massey OKI; Seif M; Compton C; Sharma R; Halpin DMG; Ismaila AS; Vogelmeier CF
BMJ Open Respir Res; 2024 May; 11(1):. PubMed ID: 38772900
[TBL] [Abstract][Full Text] [Related]
17. Adherence and Persistence to Single-Inhaler Versus Multiple-Inhaler Triple Therapy for Asthma Management.
Busse WW; Abbott CB; Germain G; Laliberté F; MacKnight SD; Jung Y; Duh MS; Averell CM
J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2904-2913.e6. PubMed ID: 35752431
[TBL] [Abstract][Full Text] [Related]
18. Once-daily long-acting beta₂-agonists/inhaled corticosteroids combined inhalers versus inhaled long-acting muscarinic antagonists for people with chronic obstructive pulmonary disease.
Sliwka A; Jankowski M; Gross-Sondej I; Storman M; Nowobilski R; Bala MM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012355. PubMed ID: 30141826
[TBL] [Abstract][Full Text] [Related]
19. When to use single-inhaler triple therapy in COPD: a practical approach for primary care health care professionals.
Gaduzo S; McGovern V; Roberts J; Scullion JE; Singh D
Int J Chron Obstruct Pulmon Dis; 2019; 14():391-401. PubMed ID: 30863039
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness of Single- versus Multiple-Inhaler Triple Therapy in a UK COPD Population: The INTREPID Trial.
Halpin DMG; Kendall R; Shukla S; Martin A; Shah D; Midwinter D; Beeh KM; Kocks JWH; Jones PW; Compton C; Risebrough NA; Ismaila AS
Int J Chron Obstruct Pulmon Dis; 2022; 17():2745-2755. PubMed ID: 36317185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]